A ‘natural’ pacemaker that mimics the heart’s variable rhythm is being trialled in humans for the first time with no adverse effects reported and the promise of improved outcomes.
The first-in-human trials started in the Waikato just before Christmas and now are being conducted in Adelaide and Melbourne, Australia, and Bristol and Cardiff in the UK.
Read the full article here.
NZ Medtech Scene
AI is transforming New Zealand's healthcare, led by the Auckland Bioengineering Institute. Innovations include Formus Labs' surgical planning and Toku Eyes' retinal diagnostics. Data integrity remains a challenge.
NZ Medtech Scene
Mike “MOD” O’Donnell is a profession director and chair, and an amateur motorcyclist. He is also an unpaid trustee of the New Zealand HiTech Trust.
NZ Medtech Scene
Fisher & Paykel Healthcare earned revenue of more than $2 billion from the sale of its medical devices for the first time.